Search Results 481-490 of 16845 for Antagonist

  1. Migraine - Diagnosis and treatment - Mayo Clinic

    Pain relievers. · Triptans. · Dihydroergotamine (Migranal, Trudhesa). · Lasmiditan (Reyvow). · Oral calcitonin gene-related peptides antagonists, also known as ...

  2. Hematology - Clinical trials

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

  3. ABSORB III Randomized Controlled Trial (RCT) - Mayo Clinic

    Any surgery requiring general anesthesia or discontinuation of aspirin and/or an adenosine diphosphate (ADP) antagonist is planned within 12 months after the ...

  4. A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome - Mayo Clinic

    ... antagonist properties, including serotonin re-uptake inhibition; triptans, atomoxetine, or other centrally-acting noradrenergic agonist; cyproheptadine, and ...

  5. Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH) - Mayo Clinic

    * Previous hepatotoxicity related to zileuton or leukotriene receptor antagonist (LTRAs) (eg montelukast). * Participants with a recent history of, or who ...

  6. Pyridorin In Diabetic Nephropathy - Clinical Trials

    Patients receiving a renin inhibitor or an aldosterone antagonist or a combination of an ACE-I and an ARB within 26 weeks of Visit 1; Patients with a history ...

  7. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

    Concomitant use of warfarin or other vitamin K antagonists. Requires treatment with a strong cytochrome P450 modulators (cytochrome P450, family 3 ...

  8. A Study of Carboplatin, Cabazitaxel and Abiraterone in High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) - Mayo Clinic

    Patients who have not yet started ADT at the time of enrollment may initiate ADT via LHRH agonist or antagonist therapy during the screening period and will ...

  9. A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    (Patients receiving proton pump inhibitors who switch to H2 receptors antagonists or antacids are eligible for enrollment to this study arm.) (3) Requires ...

  10. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    corticosteroids, immunomodulators (eg, AZA, 6-mercaptopurine, methotrexate), and/or TNF-α antagonist therapy (e.g., infliximab, adalimumab). This includes ...